Lauren Hartle
Private Equity Analyst at Prime Impact Fund
Lauren Hartle active positions
| Companies | Position | Start | End |
|---|---|---|---|
Prime Impact Fund
 Prime Impact Fund Investment ManagersFinance Prime Impact Fund (Prime Impact) is a venture capital firm founded in 2018 by Johanna Wolfson and Matthew Nordan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 31/05/2020 | - |
Career history of Lauren Hartle
Former positions of Lauren Hartle
| Companies | Position | Start | End |
|---|---|---|---|
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Corporate Officer/Principal | 31/01/2008 | 31/05/2009 |
Training of Lauren Hartle
| Harvard University | Doctorate Degree |
| University of North Carolina System | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Doctorate Degree | 1 |
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Prime Impact Fund
Prime Impact Fund Investment ManagersFinance Prime Impact Fund (Prime Impact) is a venture capital firm founded in 2018 by Johanna Wolfson and Matthew Nordan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Lauren Hartle
- Experience
